Do you want to know the progress of pharmaceutical supply chain executives adopting blockchain for their operations?
Available for Purchase: 25 October 2017
Report Fee: $835 for IEEE Members; $1,045 Standard
REPORT PURCHASE ONLINE LINK COMING SOON
IEEE Standards Association (IEEE-SA) commissioned a one-of-a-kind independent research study to examine the State of Blockchain Adoption on the Pharmaceutical Supply Chain. The report offers detailed insights on unresolved financial, regulator, and policy, and protocol issues, expectations and commitment of partners when participating on a blockchain-based pharmaceutical supply chain.
The design of the report specifically avoided the hype of projected investments and prioritization of exploring the technology. The report instead goes directly to executives who are exploring or in testing phase of the technology in pharmaceutical supply chain operations who bring a deep level of feedback on current state, next steps, what needs to happen to achieve industry-wide adoption.
Key insights of this study include:
- Perspective on which of the three key trading partners has the most to benefit and/or lose by blockchain implementation?
- Affinity for private versus public blockchain applications
- What are the key benefits that can be achieved with adoption?
- What are the perceive lack of benefits of implementing the solution?
- Deeper understanding of the unresolved issues and uncertainties impeding progress on adoption?
- What are the planned next steps for testing or implementing the technology?
- A better understanding of knowledge gaps at various levels to educate both business and technologists on this specific application.
The research study was conducted by a third-party, globally recognized research firm, Ipsos, during August 2017. The study respondents are qualified executives who have an understanding of blockchain and are currently employed within the industry. The respondents equally represented entities of the three key US-based trading partners – manufacturer, wholesaler, and dispensary (ie. Retail pharmacy and/or health facility).
If you have questions about this report or any other pharma blockchain initiatives at IEEE-SA, please write to Maria Palombini at email@example.com.
Cutting to the Trace with Blockchain
8 November 2017 – Washington, DC
The study results will be highlighted along with deep learning on applications of blockchain for FDA’s DSCSA’s compliance. See registration and session info.